Lisdexamfetamine, marketed as Vyvanse, is a controlled medication approved for attention deficit hyperactivity disorder in youngsters and adults . In Canada, its availability is managed by Health Canada. https://sandoz-lisdexamfetamine-671577.diowebhost.com/98444143/this-medication-in-canada-a-detailed-guide